Clidinium Bromide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00771 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 23 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | cauda equina syndrome | KG + DL |
| 2 | obsolete neurogenic bladder (disease) | KG + DL |
| 3 | gastroduodenitis | KG + DL |
| 4 | peptic ulcer disease | KG + DL |
| 5 | myasthenia gravis with thymus hyperplasia | KG + DL |
| 6 | myasthenia, limb-girdle, autoimmune | KG + DL |
| 7 | neonatal myasthenia gravis | KG + DL |
| 8 | autoimmune disease of peripheral nervous system | KG + DL |
| 9 | disease of receptor activity | KG + DL |
| 10 | large intestine disease | KG + DL |
| 11 | autonomic nervous system disease | KG + DL |
| 12 | small intestine disease | KG + DL |
| 13 | dysautonomia | KG + DL |
| 14 | insomnia (disease) | KG + DL |
| 15 | hypersplenism (disease) | KG + DL |
| 16 | bronchitis | KG + DL |
| 17 | atypical hemolytic-uremic syndrome with B factor anomaly | KG + DL |
| 18 | mitral valve prolapse (disease) | KG + DL |
| 19 | familial mitral valve prolapse | KG + DL |
| 20 | fetal akinesia deformation sequence | KG + DL |
| 21 | papillary conjunctivitis | KG + DL |
| 22 | MVP1 | KG + DL |
| 23 | overactive bladder (disease) | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.